CT contrast medium for detecting thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles

US9717807B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9717807-B2
Application numberUS-201314402214-A
CountryUS
Kind codeB2
Filing dateMay 13, 2013
Priority dateMay 23, 2012
Publication dateAug 1, 2017
Grant dateAug 1, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebral vascular thrombosis, and also enables the imaging monitoring of cerebral thrombus.

First claim

Opening claim text (preview).

The invention claimed is: 1. A CT contrast agent for detecting a thrombus, comprising a glycol chitosan-gold nanoparticle, to which fibrin-targeted peptide sequences represented by Formula 1 are conjugated; 2. A method of thrombus monitoring using CT imaging, comprising: 1) a step of injecting a CT contrast agent for detecting a thrombus, which comprises glycol chitosan-gold nanoparticles to which fibrin-targeted peptide sequences represented by Formula 1 are conjugated, into an animal but not a human, which has thrombosis; and 2) a step of obtaining a CT image using micro CT; 3. The method of claim 2 , wherein the animal is one type or more selected from the group consisting of dogs, mice, cats, monkeys, sheep, goats, cows, horses, and pigs. 4. The method of claim 2 , wherein the thrombosis is one type or more selected from the group consisting of cerebral thrombosis, cardiovascular thrombosis, and peripheral vascular thrombosis. 5. The method of claim 2 , further comprising a step of 3D-reconstruction of the CT image after step 2).

Assignees

Inventors

Classifications

  • Tomographic reconstruction from projections · CPC title

  • Physics · mapped topic

  • A61K49/04Primary

    X-ray contrast preparations · CPC title

  • Surface-modified nanoparticles, e.g. immuno-nanoparticles · CPC title

  • Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9717807B2 cover?
The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebr…
Who is the assignee on this patent?
Dongguk Univ Industry-Academic Coop Found, Snu R&Db Foundation, Korea Inst Sci & Tech, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61K49/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).